Farmacia Hospitalaria y Farmacogenómica

Osorio, S; Escudero-Vilaplana, V; Reguilon-Gallego, L; Gomez-Centurion, I; Diez, JL; Ferrer-Marin, F.

Severe liver toxicity in a chronic myeloid leukemia patient probably induced by a drug interaction between imatinib and sertraline

JOURNAL OF ONCOLOGY PHARMACY PRACTICE. 2019; 25(2): 484-486 Nº de citas: 4 [doi:10.1177/1078155217735689]

Rodriguez-Gonzalez, CG; Herranz-Alonso, A; Escudero-Vilaplana, V; Ais-Larisgoitia, MA; Iglesias-Peinado, I; Sanjurjo-Saez, M.

Robotic dispensing improves patient safety, inventory management, and staff satisfaction in an outpatient hospital pharmacy

JOURNAL OF EVALUATION IN CLINICAL PRACTICE. 2019; 25(1): 28-35 Nº de citas: 58 [doi:10.1111/jep.13014]

Fernandez-Cruz, A; Alba, N; Semiglia-Chong, MA; Padilla, B; Rodriguez-Macias, G; Kwon, M; Cercenado, E; Chamorro-de-Vega, E; Machado, M; Perez-Lago, L; de Viedma, DG; Martin, JLD; Munoz, P.

A Case-Control Study of Real-Life Experience with Ceftolozane-Tazobactam in Patients with Hematologic Malignancy and Pseudomonas aeruginosa Infection

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2019; 63(2): Nº de citas: 50 [doi:10.1128/AAC.02340-18]

Delgado-Ortega, L; Gonzalez-Dominguez, A; Borras, JM; Oliva-Moreno, J; Gonzalez-Haba, E; Menjon, S; Perez, P; Vicente, D; Cordero, L; Jimenez, M; Simon, S; Hidalgo-Vega, A; Moya-Alarcon, C.

The economic burden of disease of epithelial ovarian cancer in Spain: the OvarCost study

European Journal of Health Economics. 2019; 20(1): 135-147 Nº de citas: 19 [doi:10.1007/s10198-018-0986-y]

Galar, A; Munoz, P; Valerio, M; Cercenado, E; Garcia-Gonzalez, X; Burillo, A; Sanchez-Somolinos, M; Juarez, M; Verde, E; Bouza, E.

Current use of daptomycin and systematic therapeutic drug monitoring: Clinical experience in a tertiary care institution

International Journal of Antimicrobial Agents. 2019; 53(1): 40-48 Nº de citas: 47 [doi:10.1016/j.ijantimicag.2018.09.015]

Jimenez, A; Ais, A; Beaudet, A; Gil, A.

Determining the value contribution of selexipag for the treatment of pulmonary arterial hypertension (PAH) in Spain using reflective multi-criteria decision analysis (MCDA)

Orphanet Journal of Rare Diseases. 2018; 13: 220-220 Nº de citas: 26 [doi:10.1186/s13023-018-0966-4]

Perez-Granda, MJ; Alonso, B; Rodriguez-Huerta, A; Rodriguez, C; Guembe, M.

In vitro assessment of the anti-biofilm activity of ethanol alone and in combination with enoxaparin 60 IU

ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA. 2018; 36(10): 627-632 Nº de citas: 1 [doi:10.1016/j.eimc.2017.11.007]

Revuelta-Herrero, JL; Gimenez-Manzorro, A; Matilla-Pena, A; Herranz-Alonso, A; Sanjurjo-Saez, M.

Concomitant use of sorafenib with ombitasvir/paritaprevir/ritonavir and dasabuvir: Effectiveness and safety in clinical practice

JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS. 2018; 43(6): 906-909 Nº de citas: 4 [doi:10.1111/jcpt.12727]

Lopez-Fernandez, LA.

ATP-Binding Cassette Transporters in the Clinical Implementation of Pharmacogenetics

Journal of Personalized Medicine. 2018; 8(4): Nº de citas: 11 [doi:10.3390/jpm8040040]

Romero-Jimenez, RM; Escudero-Vilaplana, V; Baniandres Rodriguez O; Garcia Martin E; Mateos Mayo A; Sanjurjo Saez M.

Association between clinical factors and dose modification strategies in the treatment with ustekinumab for moderate-to-severe plaque psoriasis

JOURNAL OF DERMATOLOGICAL TREATMENT. 2018; 29(8): 792-796 Nº de citas: 14 [doi:10.1080/09546634.2018.1466978]

ALONSO FERNANDEZ, BEATRIZ; PEREZ GRANDA, MARIA JESUS; RODRÍGUEZ HUERTA, ANA MARÍA; RODRÍGUEZ GONZÁLEZ, CARMEN GUADALUPE; BOUZA SANTIAGO, EMILIO.

The optimal ethanol lock therapy regimen for treatment of biofilm-associated catheter infections: an in-vitro study

Journal of Hospital Infection. 2018; 100(3): 187-195 Nº de citas: 14 [doi:10.1016/j.jhin.2018.04.007]

Osorio, S; Escudero-Vilaplana, V; Gomez-Centurion, I; Perez-Lopez, R; Ayala, R; Vall-Llovera, F; Garcia-Gutierrez, V; Casares, MTG; Miguel, JDGS; Hernandez-Rivas, JA; Sanchez-Guijo, F; Martinez-Garcia, AB; Villalon, L; Conesa-Garcia, V; Rodriguez, A; Casado, F; Garcia-Gonzalez, X; Perdomo, MNS; Banos, U; Steegmann, JL.

Drug-to-drug interactions of tyrosine kinase inhibitors in chronic myeloid leukemia patients. Is it a real problem?

ANNALS OF HEMATOLOGY. 2018; 97(11): 2089-2098 Nº de citas: 26 [doi:10.1007/s00277-018-3413-7]

Gonzalez-Hada-Pena, E; Manrique-Rodriguez, S; Herranz-Alonso, AM; Iglesias-Peinado, I; Sanjurjo-Sáez M.

A comparative study of contamination in three closed systems for the preparation of hazardous drugs through simulations with fluorescein

FARMACIA HOSPITALARIA. 2018; 42(6): 234-238 Nº de citas: 5 [doi:10.7399/fh.11024]

Collado-Borrell, R; Escudero-Vilaplana, V; Calles, A; Garcia-Martin, E; Marzal-Alfaro, B; Gonzalez-Haba, E; Herranz-Alonso, A; Sanjurjo-Saez, M.

Oncology Patient Interest in the Use of New Technologies to Manage Their Disease: Cross-Sectional Survey

JOURNAL OF MEDICAL INTERNET RESEARCH. 2018; 20(10): Nº de citas: 38 [doi:10.2196/11006]

Salvador-Martin, S; Garcia-Gonzalez, X; Garcia, MI; Blanco, C; Garcia-Alfonso, P; Robles, L; Gravalos, C; Pachon, V; Longo, F; Martinez, V; Sanjurjo-Saez, M; Lopez-Fernandez, LA.

Clinical utility of ABCB1 for preventing toxicity in treatment with irinotecan

PHARMACOLOGICAL RESEARCH. 2018; 136: 133-139 Nº de citas: 21 [doi:10.1016/j.phrs.2018.08.026]

Valerio, M; Vena, A; Rodriguez-Gonzalez, CG; de Vega, EC; Mateos, M; Sanjurjo, M; Bouza, E; Munoz, P.

Repeated antifungal use audits are essential for selecting the targets for intervention in antifungal stewardship

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES. 2018; 37(10): 1993-2000 Nº de citas: 18 [doi:10.1007/s10096-018-3335-2]

Amor-Garcia, MA; Ibanez-Garcia, S; Diaz-Redondo, A; Alonso, AH; Saez, MS.

Multidisciplinary strategy to reduce errors with the use of medical gases

FARMACIA HOSPITALARIA. 2018; 42(3): 103-107 Nº de citas: 1 [doi:10.7399/fh.10920]

Marzal-Alfaro, MB; Barbero, MLM; Dominguez, JMG; Romero-Delgado, F; Gines, MLM; Herranz, A; Sanjurjo-Saez, M.

Impact of fampridine on quality of life: clinical benefit in real-world practice

European Journal of Hospital Pharmacy. 2018; 25(3): 138-143 Nº de citas: 7 [doi:10.1136/ejhpharm-2016-001129]